Answers are grounded in this paper and cite their sources.
The authors revisit the current FDA warnings applied to the use of sirolimus in liver transplantation, indicating that they are best considered in the context of comprehensive clinical trial data. See article by Abdelmalek et al on page 694.
No takes yet. Share an insight, caveat, or question.
McKenna et al. (2012) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: